Association with outcomes and response to treatment of trimethylamine N ‐oxide in heart failure: results from BIOSTAT‐CHF

ConclusionTMAO levels were associated with adverse outcomes (mortality and/or rehospitalisation) in BIOSTAT ‐CHF, and did not respond to guideline‐based pharmacological treatment in contrast to BNP levels which did as expected. Lower TMAO levels were associated with favourable outcome regardless of treatment.

https://onlinelibrary.wiley.com/doi/abs/10.1002/ejhf.1338?af=R

Source: European Journal of Heart Failure - July 27, 2019 Category: Cardiology Authors: Toru Suzuki, Yoshiyuki Yazaki, Adriaan A. Voors, Donald J.L. Jones, Daniel C.S. Chan, Stefan D. Anker, John G. Cleland, Kenneth Dickstein, Gerasimos Filippatos, Hans L. Hillege, Chim C. Lang, Piotr Ponikowski, Nilesh J. Samani, Dirk J. van Ve Tags: RESEARCH ARTICLE Source Type: research